Vifor Fresenius Medical Care Renal Pharma Ltd., 10% Owner at ChemoCentryx, Inc. (CCXI), sold 4,000,000 shares at $39.43 ($157.7M) on 2021-10-12, disclosed to the SEC on 2021-10-13.
Open-market sale of $157.7M CCXI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CCXI | SELL | 2020-07-13 | $28.5M | — | Filing → |